Fosfomycin calcium

磷霉素钙

Report date: 2023/02/27 09:46:55

Base Information

Drug NameFosfomycin calcium
Drug Alias NameFosfomycin Calcium
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeptidoglycan inhibitorsCell wall inhibitors
TargetsPeptidoglycan
Therapy Area/IndicationsFebrile NeutropeniaBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryJapan
Original Approved Date1980/06/10
Country/TerritorySpainMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBiostar Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesFundación Para La Investigación Biosanitaria Del Principado De AsturiasMeiji Seika Pharmatech Co LtdHubei Wudang Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsFebrile NeutropeniaBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A